ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143 | -11.2% | 7,963 | +0.5% | 0.00% | – |
| Q2 2023 | $161 | -41.5% | 7,921 | -37.3% | 0.00% | – |
| Q1 2023 | $275 | -48.2% | 12,642 | -26.3% | 0.00% | -100.0% |
| Q4 2022 | $531 | -99.8% | 17,142 | +25.6% | 0.00% | 0.0% |
| Q3 2022 | $348,000 | +26.1% | 13,653 | +0.3% | 0.00% | – |
| Q2 2022 | $276,000 | -18.3% | 13,609 | -0.3% | 0.00% | – |
| Q1 2022 | $338,000 | -24.2% | 13,647 | +6.4% | 0.00% | – |
| Q4 2021 | $446,000 | +27.8% | 12,828 | -0.3% | 0.00% | – |
| Q3 2021 | $349,000 | -19.6% | 12,861 | -23.2% | 0.00% | – |
| Q2 2021 | $434,000 | -3.1% | 16,738 | -19.4% | 0.00% | – |
| Q1 2021 | $448,000 | -3.0% | 20,766 | -3.3% | 0.00% | -100.0% |
| Q4 2020 | $462,000 | +45.7% | 21,466 | 0.0% | 0.00% | – |
| Q3 2020 | $317,000 | -34.0% | 21,466 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $480,000 | +58.4% | 21,466 | 0.0% | 0.00% | – |
| Q1 2020 | $303,000 | -26.3% | 21,466 | -15.2% | 0.00% | – |
| Q4 2019 | $411,000 | -53.6% | 25,300 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $885,000 | -37.8% | 25,300 | +0.4% | 0.00% | -50.0% |
| Q2 2019 | $1,422,000 | -7.7% | 25,200 | +19.4% | 0.00% | 0.0% |
| Q1 2019 | $1,541,000 | +29.2% | 21,100 | +12.8% | 0.00% | 0.0% |
| Q4 2018 | $1,193,000 | -48.6% | 18,700 | -19.5% | 0.00% | -33.3% |
| Q3 2018 | $2,319,000 | +40.5% | 23,239 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $1,651,000 | -27.4% | 23,239 | +6.4% | 0.00% | -33.3% |
| Q1 2018 | $2,273,000 | +61.4% | 21,839 | +56.2% | 0.00% | +50.0% |
| Q4 2017 | $1,408,000 | +374.1% | 13,984 | +64.5% | 0.00% | – |
| Q3 2017 | $297,000 | +76.8% | 8,500 | +21.4% | 0.00% | – |
| Q2 2017 | $168,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |